CD4 and CD8 T lymphocyte interplay in controlling tumor growth.

CD4 and CD8 T lymphocyte interplay in controlling tumor growth.
复制标题

DOI:
10.1007/s00018-017-2686-7
复制
发表时间:
2018-03
期刊:
Cellular and molecular life sciences : CMLS
影响因子:
--
通讯作者:
Woller N
Woller N
中科院分区:
其他
文献类型:
--
作者:
Ostroumov D;Fekete-Drimusz N;Saborowski M;Kühnel F;Woller N

文献摘要

参考文献

被引文献

相似文献

免疫检查点阻断的杰出临床成功重新唤起了人们对免疫系统潜在机制的兴趣,这些机制即使在晚期也能够消除肿瘤。在这种情况下,CD4和CD8 T细胞反应是癌症免疫周期的一部分,两个群体都显著影响临床结果。一般来说,免疫系统已经进化出几种机制来保护宿主免受癌症的侵害。在癌症发展过程中,它们中的每一个都必须被破坏或逃避,以使肿瘤生长。在这篇综述中,我们概述了T淋巴细胞驱动的肿瘤生长控制,并讨论了免疫系统的肿瘤抑制机制,如衰老监视,癌症免疫监视和癌症免疫编辑方面的最新临床发展的免疫治疗。主要关注的是目前现有的知识CD4和CD8 T淋巴细胞的相互作用,介导的肿瘤生长的控制。
The outstanding clinical success of immune checkpoint blockade has revived the interest in underlying mechanisms of the immune system that are capable of eliminating tumors even in advanced stages. In this scenario, CD4 and CD8 T cell responses are part of the cancer immune cycle and both populations significantly influence the clinical outcome. In general, the immune system has evolved several mechanisms to protect the host against cancer. Each of them has to be undermined or evaded during cancer development to enable tumor outgrowth. In this review, we give an overview of T lymphocyte-driven control of tumor growth and discuss the involved tumor-suppressive mechanisms of the immune system, such as senescence surveillance, cancer immunosurveillance, and cancer immunoediting with respect to recent clinical developments of immunotherapies. The main focus is on the currently existing knowledge about the CD4 and CD8 T lymphocyte interplay that mediates the control of tumor growth.
DOI: 10.4161/onci.21285
发表时间: 2012-11-01
期刊: Oncoimmunology
影响因子: 7.2
作者:
Bos R;Marquardt KL;Cheung J;Sherman LA
通讯作者: Sherman LA
DOI: 10.1111/j.1365-3083.1995.tb03584.x
发表时间: 1995-04-01
影响因子: 3.7
作者:
CABRERA, T;RUIZCABELLO, F;GARRIDO, F
通讯作者: GARRIDO, F
DOI: 10.1158/0008-5472.can-16-1638
发表时间: 2017-06-01
期刊: Cancer research
影响因子: 11.2
作者:
Bartee MY;Dunlap KM;Bartee E
通讯作者: Bartee E
DOI: 10.4049/jimmunol.169.2.739
发表时间: 2002-07-15
影响因子: 4.4
作者:
Arnold, PY;La Gruta, NL;Vignali, DAA
通讯作者: Vignali, DAA
DOI: 10.1056/nejmoa1200694
发表时间: 2012-06-28
期刊: The New England journal of medicine
影响因子: --
作者:
Brahmer JR;Tykodi SS;Chow LQ;Hwu WJ;Topalian SL;Hwu P;Drake CG;Camacho LH;Kauh J;Odunsi K;Pitot HC;Hamid O;Bhatia S;Martins R;Eaton K;Chen S;Salay TM;Alaparthy S;Grosso JF;Korman AJ;Parker SM;Agrawal S;Goldberg SM;Pardoll DM;Gupta A;Wigginton JM
通讯作者: Wigginton JM